COVID-19 Vaccine intent in appalachian patients with multiple sclerosis.

Wu, Hongyan; Ward, Melanie; Brown, Ashlyn; Blackwell, Erica; Umer, Amna

Wu, Hongyan; Ward, Melanie; Brown, Ashlyn; Blackwell, Erica; Umer, Amna.

Afiliação

Wu H; Department of Neurology, School of Medicine, West Virginia University, Morgantown, West Virginia 26506, USA. Electronic address: hongyan.wu@wvumedicine.org.
Ward M; Department of Neurology, School of Medicine, West Virginia University, Morgantown, West Virginia 26506, USA.
Brown A; School of Medicine Charleston Division, West Virginia University, Charleston, West Virginia 25304 USA.
Blackwell E; Department of Neurology, School of Medicine, West Virginia University, Morgantown, West Virginia 26506, USA.
Umer A; Department of Pediatrics, School of Medicine, West Virginia University, Morgantown, West Virginia 26506 USA.

Mult Scler Relat Disord ; 57: 103450, 2022 Jan.

Article em En | MEDLINE | ID: mdl-34911005

Assuntos

COVID-19; Vacinas contra Influenza; Esclerose Múltipla; Adulto; Vacinas contra COVID-19; Estudos Transversais; Feminino; Humanos; Pessoa de Meia-Idade; Esclerose Múltipla/epidemiologia; Pandemias; SARS-CoV-2; Estados Unidos; Vacinação

Palavras-chave

Appalachian; COVID-19 vaccine; Multiple sclerosis; Vaccine hesitancy; Vaccine intent

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / COVID-19 / Esclerose Múltipla Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google